We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

25 hedge funds and large institutions have $5.58M invested in Filana Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

18% more capital invested

Capital invested by funds: $4.72M → $5.58M (+$861K)

4% more funds holding

Funds holding: 24 → 25 (+1)

0.96% less ownership

Funds ownership: 33.26% → 32.3% (-0.96%)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$3.29M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$1.19M
3
Renaissance Technologies
Renaissance Technologies
New York
+$354K
4
ARTA
A.R.T. Advisors
New York
+$87.3K
5
VF
Virtu Financial
New York
+$70.9K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$124K
2
BCM
Bridgeway Capital Management
Texas
-$49K
3
JMPWA
JP Morgan Private Wealth Advisors
California
-$28K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$26.4K
5
ZIM
Zacks Investment Management
Illinois
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$2.19M +$3.29M +2,164,000 New
First Eagle Investment Management
2
First Eagle Investment Management
New York
$1.74M +$1.19M +784,314 +84%
NCM
3
Nantahala Capital Management
Connecticut
$654K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$264K +$354K +233,121 +834%
Vanguard Group
5
Vanguard Group
Pennsylvania
$221K +$56.9K +37,466 +21%
BlackRock
6
BlackRock
New York
$205K +$1.3K +859 +0.4%
VF
7
Virtu Financial
New York
$67K +$70.9K +46,628 +239%
ARTA
8
A.R.T. Advisors
New York
$58K +$87.3K +57,438 New
Northern Trust
9
Northern Trust
Illinois
$43K – – –
PAM
10
Panagora Asset Management
Massachusetts
$40K +$60.5K +39,801 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$38K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$22K -$26.4K -17,349 -44%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$14K – – –
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$12K -$1.49K -977 -8%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$12K -$62 -41 -0.3%
UBS Group
16
UBS Group
Switzerland
$6K -$2.04K -1,345 -18%
Bank of America
17
Bank of America
North Carolina
$2K -$435 -286 -11%
FANJ
18
Financial Architects (New Jersey)
New Jersey
$1K – – –
Morgan Stanley
19
Morgan Stanley
New York
$1K – – –
Wells Fargo
20
Wells Fargo
California
$1K – – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
– -$124K -59,989 Closed
BCM
22
Bridgeway Capital Management
Texas
– -$49K -23,922 Closed
JMPWA
23
JP Morgan Private Wealth Advisors
California
– -$28K -13,700 Closed
ZIM
24
Zacks Investment Management
Illinois
– -$23K -11,373 Closed
AG
25
Advisor Group
Arizona
– -$456 -300 -89%
1
2

FLNA Hedge Fund Activity: Q3 2018 in Review

25 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2018, worth a combined $5.58M — up 18% from $4.72M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new FLNA positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $3.29M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $124K sold.

  • 25 institutional investors held Filana Therapeutics (FLNA) as of Q3 2018, up from 24 in Q2 2018.
  • Funds reported $5.58M of Filana Therapeutics stock for Q3 2018, up 18% quarter-over-quarter.
  • 6 funds opened new Filana Therapeutics positions in Q3 2018 and 5 closed out, a net change of +1 holder.
  • The largest Filana Therapeutics buyer in Q3 2018 was Armistice Capital, an estimated $3.29M added.
  • The largest Filana Therapeutics seller in Q3 2018 was Dimensional Fund Advisors, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2018.